Cancer Research Horizons Investor

We are a specialist drug discovery, development and commercialisation company, taking cutting edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.

Headquarters: 2 Redman Place, London
Founded Date: 2002-01-01
Investor Type: Venture Capital
Estimated Revenue: $1M to $10M
Investors Number: 3